Newsfeeds Archive - Page 11 of 696

4 minute read

Mereo BioPharma Reports On Recent Program Developments And Provides Financial Update; As Of September 30, 2023, The Company Had Cash And Short-Term Deposits Of $62.4M

October 23, 4:04 PM

Mereo BioPharma Group plc (NASDAQ:MREO) ("Mereo" or the "Company"), a clinical-stage biopharmaceutical company focused on rare diseases, today provided an update on recent program developments

MREO

3 minute read

Senmiao Technology Announces Ride-Hailing Platform Operating Metrics For September 2023; Senmiao And Its Affiliates Recorded 0.61M Total Completed Orders, Compared To 0.62M Total Orders Completed MoM

By Happy Mohamed

October 23, 9:19 AM

Senmiao Technology Limited ("Senmiao" or the "Company") (NASDAQ:AIHS), a financing and servicing company focused on the online ride-hailing industry in China as well as an operator of its

AIHS

2 minute read

Disc Medicine Announces Planned Departure Of Chief Financial Officer Joanne Bryce; Co Initiated A Search To Fill The Position. Ms. Bryce Plans To Remain With The Co And Oversee Her Current Responsibilities Until A Successor Has Been Identified

By Happy Mohamed

October 23, 9:17 AM

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases,

IRON

5 minute read

CEL-SCI Corporation Announces 5-Year Head & Neck Cancer Survival Increased From 45% To 73% In Co’s Target Population, Cutting Risk Of Death In Half, As Presented At Leading Cancer Conference ESMO 2023

By Happy Mohamed

October 23, 9:16 AM

Target patient population for regulatory submissions finalized: Patients with low PD-L1, in contrast tocurrent checkpoint inhibitors which work best with high PD-L1. Addressing unmet need in ~145,000 head and

CVM

3 minute read

Cyclo Therapeutics Announces Early Exercise Of Warrants By Board Members, Management And A Significant Shareholder Resulting In Cash Proceeds Of $2.4M

By Happy Mohamed

October 23, 8:18 AM

Issues New Warrants to this Investment Group for Possible Additional Funding of Up to $3.47 Million (if exercised) Cyclo Therapeutics, Inc. (NASDAQ:CYTH) ("Cyclo Therapeutics" or the

CYTH

2 minute read

News

IPA Provides Update On Growth Strategy And Recent Share Price Movement

By Happy Mohamed

October 23, 8:18 AM

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) ("IPA" or the "Company"), an AI-driven biotherapeutic research and technology company wishes to provide an update on its overall growth strategy,

IPA

3 minute read

PDS Biotech Announces Preliminary Biomarker Study Results In Subset Of Advanced HPV-Positive Head And Neck Cancer Patients At ESMO

By Happy Mohamed

October 23, 8:16 AM

Combination of PDS0101 and KEYTRUDA® appears to lead to changes towards a TH1 predominant cytokine profile reported to be associated with improved killer T cell activity Lowered CD8 T cells in peripheral

PDSB

2 minute read

Legal
News

Strategic Collaboration Between Amazon’s Counterfeit Crimes Unit And The Prada Group Leads To International Counterfeiter’s Guilty Plea

By Happy Mohamed

October 23, 8:15 AM

A Chinese court returns a favorable decision in a case that relied primarily on the bad actor's overseas sales data and inventory provided by Amazon. Amazon's Counterfeit Crimes Unit (CCU), the Prada Group, and

AMZN

3 minute read

Galecto Presents Updated Clinical Data At ESMO Congress 2023 And Provides Update On Phase 1b/2a GALLANT-1 Trial

By Happy Mohamed

October 23, 8:14 AM

Galecto, Inc. (NASDAQ:GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today presented a poster with new and encouraging clinical data, including two

GLTO

2 minute read

SIGA Announces Creation Of Joint Procurement Mechanism By European Commission With Anticipated Initial Orders Of ~$18M For Oral TPOXX By Participating Countries

By Happy Mohamed

October 23, 8:12 AM

SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced the creation by the European Commission's DG HERA (Health

SIGA